DocGo Inc. (DCGO) Stock Forecast

NASDAQ: DCGOAnalyst ratings, price target and estimates.

DCGO analyst forecast

as of October 18, 2026
Analyst consensus
Buy
3.60 / 5 from 5 analysts
Price target
$1.88
average of analyst targets
Upside to target
+589.4%
from the latest close
Next earnings
November 9, 2026
EPS estimate $-0.04
52-week range
$0.27 – $1.49

DCGO analyst ratings

5 analysts
Strong buy
120%
Buy
120%
Hold
360%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

DCGO price target

Price $0.27Target $1.88
52-week low $0.2752-week high $1.49

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

DCGO earnings per share estimates

DocGo Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.13−$0.15−$0.11−$0.25+47.9%2
Current fiscal year (2026)−$0.79−$0.92−$0.67−$1.80+55.9%2
Next fiscal year (2027)$0.14−$0.04$0.32−$0.79+117.9%2

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

DCGO revenue estimates

DocGo Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$77.2M$76.0M$78.6M+9.1%5
Current fiscal year (2026)$306.5M$305.0M$307.5M−4.9%5
Next fiscal year (2027)$325.8M$321.5M$328.4M+6.3%5

DCGO EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

DCGO revenue: reported and forecast

Reported revenueEstimate (average; low–high)

DCGO EPS estimate revisions

DocGo Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.02−$0.02−$0.02−$0.02−$0.13+684.8%0 up · 1 down
Current fiscal year (2026)−$0.42−$0.42−$0.42−$0.42−$0.79+86.9%0 up · 1 down
Next fiscal year (2027)$0.19$0.19$0.19$0.19$0.14−23.8%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

DCGO earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; DCGO beat in 5 of 12.

What analysts expect from DCGO

5 analysts cover DocGo; their consensus rating is buy (3.60 on a 1–5 scale, where 5 is a strong buy). The average price target is $1.88, 589.4% above the latest close of $0.27. Analysts expect earnings of −$0.79 per share for 2026, +55.9% from a year earlier. For 2027 the average estimate is $0.14 per share on revenue of $325.8 million. DocGo beat the EPS estimate in 5 of the last 12 quarters.

Related: DCGO income statement, DCGO key metrics, DCGO chart. See the DCGO stock overview for the latest quote and news.

DCGO forecast FAQ

What is DocGo's price target?

The average analyst price target for DocGo is $1.88, 589.4% above the latest close of $0.27.

Is DocGo a buy, hold or sell?

Of 5 analysts covering DocGo, 1 rate it a strong buy, 1 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is DocGo's EPS forecast?

Analysts forecast −$0.79 per share for 2026 (range −$0.92 to −$0.67); for 2027 the estimate is $0.14.

What is DocGo's revenue forecast?

The average revenue estimate for 2026 is $306.5 million, growth of −4.9%; for 2027 it is $325.8 million.

When does DocGo report earnings?

DocGo is expected to report results for the quarter ending September 30, 2026 on November 9, 2026 after the market closes; the EPS estimate is $-0.04.

Does DocGo usually beat earnings estimates?

DocGo reported EPS at or above the analyst estimate in 5 of the last 12 quarters.

Medical Care Facilities: forecast